BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Chemaphor Inc. Intends to Complete Private Placement

  September 28, 2009

   · 

  3 min read
• ChinaBio Today: The Week in Review: Three Life Science Companies to IPO on GEM

  September 28, 2009

   · 

  1 min read
• Invitation to the Extraordinary General Meeting of BioTie Therapies Corp.

  September 28, 2009

   · 

  7 min read
• Business

  Peter Fellner Nominated to be Elected to BioTie Therapies Corp.'s Board of Directors

  September 28, 2009

   · 

  1 min read
• Horiba Medical: Safe Intelligent Haematology Auto-Validation At Airedale

  September 28, 2009

   · 

  4 min read
• Demand for Therapies to Treat Drug Resistant HIV Strains is Increasing, Finds Frost & Sullivan

  September 28, 2009

   · 

  3 min read
• Biotech Bay

  AnaSpec, Inc.'s Published References Pass 800

  September 28, 2009

   · 

  1 min read
• Drug Development

  Celsion Corporation Initiates Enrollment Awareness Program for Pivotal Phase I/II DIGNITY Trial of ThermoDox(R) in Patients with Recurrent Chest Wall (RCW) Breast Cancer

  September 28, 2009

   · 

  5 min read
• Policy

  Merck Sharp & Dohme Receives Positive CHMP Opinion for ‘Januvia(R)’ and ‘Janumet(R)’ as Add-On to Insulin in the European Union

  September 28, 2009

   · 

  7 min read
• BioForest

  Cell Therapeutics, Inc. Finalizes Asset Sale and Closure of Italian Branch, Saves $20 Million in 2010 Annual Operating Expenses

  September 28, 2009

   · 

  2 min read